Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: replacement therapeutics - Glycomine

Next Previous
Drug Profile

Research programme: replacement therapeutics - Glycomine

Alternative Names: M1P; Mannose-1-phosphate; PMM2-CDG; Recombinant human N-glycanase 1; rhNgly1

Latest Information Update: 25 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Glycomine
  • Class Enzymes; Sugar phosphates
  • Mechanism of Action Enzyme replacements; Mannose replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Congenital disorder of glycosylation type 1A
  • No development reported Inborn error metabolic disorders

Most Recent Events

  • 23 Jun 2021 Preclinical trials in Congenital disorder of glycosylation type 1A in USA (unspecified route)
  • 28 Dec 2020 No recent reports of development identified for early research in Inborn-error-metabolic-disorders in USA
  • 16 Nov 2016 Early research in Inborn error metabolic disorders in USA (unspecified route)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top